Published in Eur J Epidemiol on January 01, 2005
Association between alcohol consumption and cancers in the Chinese population--a systematic review and meta-analysis. PLoS One (2011) 1.20
Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study. PLoS One (2014) 0.92
Risk factors for sporadic colorectal cancer in southern Chinese. World J Gastroenterol (2009) 0.87
Alcohol intake and risk of colorectal cancer: results from the UK Dietary Cohort Consortium. Br J Cancer (2010) 0.85
Alcohol consumption and risk of colorectal cancer: the Findrink study. Eur J Epidemiol (2008) 0.84
Colorectal cancer: molecules and populations. J Natl Cancer Inst (1999) 4.39
Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res (1997) 3.36
Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18
Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst (1995) 3.10
A meta-analysis of alcohol drinking and cancer risk. Br J Cancer (2001) 2.47
A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes Control (1990) 2.25
Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer (1977) 1.54
Alcohol drinking. IARC Working Group, Lyon, 13-20 October 1987. IARC Monogr Eval Carcinog Risks Hum (1988) 1.52
Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol (2002) 1.09
Folate, methionine, alcohol, and colorectal cancer in a prospective study of women in the United States. Cancer Causes Control (2002) 0.95
Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas. Cancer Lett (2000) 0.86
Nested case-control study on the risk factors of colorectal cancer. World J Gastroenterol (2003) 0.81
[Alcohol and cancer]. Pathol Biol (Paris) (2001) 0.77
Cancer incidence in five continents. Volume IV. IARC Sci Publ (1982) 0.76
Reverse passive hemagglutination for detection of fecal occult blood. A comparison with Japanese Immudia-Hem SP Kit. Chin Med J (Engl) (1988) 0.75
[Prevention of hepatocellular carcinoma]. Praxis (Bern 1994) (2002) 0.75
Cancer survival in China, 2003-2005: a population-based study. Int J Cancer (2014) 3.32
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma. J Nucl Med (2007) 2.83
NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell (2010) 2.49
Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc Natl Acad Sci U S A (2005) 2.42
Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med (2012) 2.42
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol (2011) 2.15
Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis. Schizophr Bull (2011) 1.98
Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ Sci Technol (2006) 1.98
The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics (2011) 1.79
Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat (2002) 1.60
High environmental relative moldiness index during infancy as a predictor of asthma at 7 years of age. Ann Allergy Asthma Immunol (2011) 1.58
MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett (2008) 1.56
Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res (2004) 1.51
A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. Ann Allergy Asthma Immunol (2011) 1.47
Diagnostic inconsistency of faecal immunochemical tests for haemoglobin in population screening of colorectal cancer. Clin Chem Lab Med (2013) 1.46
Infant origins of childhood asthma associated with specific molds. J Allergy Clin Immunol (2012) 1.44
MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med Oncol (2011) 1.39
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT. Radiology (2011) 1.30
Helicobacter pylori infection and gastric cancer: evidence from a retrospective cohort study and nested case-control study in China. World J Gastroenterol (2002) 1.29
A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer. J Nucl Med (2007) 1.29
Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia. Blood (2005) 1.29
Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer (2002) 1.27
Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers. Clin Cancer Res (2011) 1.23
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. Am J Nucl Med Mol Imaging (2013) 1.21
Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol (2004) 1.21
Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma. Hepatology (2007) 1.18
ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers. OMICS (2010) 1.17
Special fasciculiform cataract caused by a mutation in the gammaD-crystallin gene. Mol Vis (2004) 1.17
An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. World J Gastroenterol (2004) 1.16
Epidermal growth factor receptor-regulated miR-125a-5p--a metastatic inhibitor of lung cancer. FEBS J (2009) 1.16
Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull (2012) 1.14
Transformed immortalized gastric epithelial cells by virulence factor CagA of Helicobacter pylori through Erk mitogen-activated protein kinase pathway. Oncogene (2005) 1.14
Networks link antigenic and receptor-binding sites of influenza hemagglutinin: mechanistic insight into fitter strain propagation. Sci Rep (2011) 1.14
Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLoS One (2010) 1.14
Cluster randomization trial of sequence mass screening for colorectal cancer. Dis Colon Rectum (2003) 1.13
Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis. Appl Radiat Isot (2003) 1.11
Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans. J Nucl Med (2007) 1.11
Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B. Mol Cell Biol (2007) 1.11
Barriers to colorectal cancer screening: a case-control study. World J Gastroenterol (2009) 1.11
Performance of a colorectal cancer screening protocol in an economically and medically underserved population. Cancer Prev Res (Phila) (2011) 1.10
A giant hemolymphangioma of the pancreas in a 20-year-old girl: a report of one case and review of the literature. World J Surg Oncol (2009) 1.09
Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers. Clin Sci (Lond) (2013) 1.08
Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway. Cancer Lett (2012) 1.08
Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol (2004) 1.08
Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer. Cancer Res (2011) 1.08
Pro-apoptotic mechanisms of action of a novel vitamin E analog (alpha-TEA) and a naturally occurring form of vitamin E (delta-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer (2004) 1.07
Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. Gan To Kagaku Ryoho (2002) 1.07
A distinct metabolic signature of human colorectal cancer with prognostic potential. Clin Cancer Res (2014) 1.06
Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs (2005) 1.06
Detection and identification of potential biomarkers of breast cancer. J Cancer Res Clin Oncol (2010) 1.06
microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer (2014) 1.05
Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev (2005) 1.04
Autosomal dominant coralliform cataract related to a missense mutation of the gammaD-crystallin gene. Chin Med J (Engl) (2004) 1.04
Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression. Cell Microbiol (2007) 1.04
Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol Carcinog (2010) 1.03
Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents. Med Res Rev (2011) 1.03
CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine. Blood (2012) 1.02
Vitamin E and cancer. Vitam Horm (2007) 1.00
Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients. World J Gastroenterol (2011) 1.00
Discovery and identification of potential biomarkers of papillary thyroid carcinoma. Mol Cancer (2009) 0.99
Knockdown of OLA1, a regulator of oxidative stress response, inhibits motility and invasion of breast cancer cells. J Zhejiang Univ Sci B (2009) 0.99
Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells. Prostate (2008) 0.99
Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis. PLoS One (2013) 0.97
Young patients (≤ 35 years old) with colorectal cancer have worse outcomes due to more advanced disease: a 30-year retrospective review. Medicine (Baltimore) (2014) 0.96
SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer. Breast (2005) 0.96
Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors. Mol Biol Rep (2011) 0.96
Association between H-RAS T81C genetic polymorphism and gastrointestinal cancer risk: a population based case-control study in China. BMC Cancer (2008) 0.96
Vitamin E and breast cancer. J Nutr (2004) 0.95
Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol (2011) 0.95
In vivo and in vitro studies of anticancer actions of alpha-TEA for human prostate cancer cells. Prostate (2008) 0.95
Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol (2003) 0.95
Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation. Cancer Sci (2008) 0.95
Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway. J Zhejiang Univ Sci B (2009) 0.95
SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer. World J Gastroenterol (2011) 0.95
Impact of a laparoscopic resection on the quality of life in rectal cancer patients: results of 135 patients. Surg Today (2010) 0.94
Cytochrome P450 drives a HIF-regulated behavioral response to reoxygenation by C. elegans. Science (2013) 0.94
Wnt modulates MCL1 to control cell survival in triple negative breast cancer. BMC Cancer (2014) 0.93
An integrated approach utilizing proteomics and bioinformatics to detect ovarian cancer. J Zhejiang Univ Sci B (2005) 0.93
Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trial. World J Gastroenterol (2004) 0.93
Non-organ-specific preventive effect of long-term administration of Korean red ginseng extract on incidence of human cancers. J Med Food (2010) 0.93
CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high- incidence area in north China. World J Gastroenterol (2003) 0.92
Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers. Clin Cancer Res (2012) 0.92
The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population. Mol Carcinog (2010) 0.91
Identification of novel serum biomarkers in child nephroblastoma using proteomics technology. Mol Biol Rep (2010) 0.91
Expression of SNC73, a transcript of the immunoglobulin alpha-1 gene, in human epithelial carcinomas. World J Gastroenterol (2007) 0.91
Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients. J Zhejiang Univ Sci B (2006) 0.91
Potent antitumor activity of double-regulated oncolytic adenovirus-mediated ST13 for colorectal cancer. Cancer Sci (2009) 0.91
Landscape of the SOX2 protein-protein interactome. Proteomics (2011) 0.91